Pharmatics

What Pharmatics does

Pharmatics Limited is a privately held UK company founded in 2011 and headquartered at Edinburgh Bioquarter, operating with 11-50 employees under the leadership of founder and CEO Felix Agakov. The company develops MedAI, a proprietary AI pipeline that uses Large Language Models, natural language processing, and information retrieval to convert scientific biomedical articles, clinical trials, and systematic reviews into predictive models, claiming synthesis of millions of person-years of medical evidence into a priori predictive tools. MedAI is delivered through three service lines: Evidence (pre-trained predictive models from scientific literature), Data (AI/ML development on real-world health data including biomarkers, sensors, images, and PROMs), and Integration (API access and deployment into client software products).

The company targets B2B enterprise clients in digital health and precision medicine, including digital health solution providers, healthcare providers, and research organizations. Distribution combines enterprise field sales with an API-first developer channel; pricing is quote-based and undisclosed, with revenue appearing to derive from a mix of project-based engagements and recurring API/subscription access. No named customers, funding rounds, partnerships, or acquisitions are disclosed, and the ownership structure appears founder-led with no institutional investors identified in the input data.

Performance claims include an 18-month reduction in development time, 20% improvement over auto-ML methods, and 10-30% improvement in interpretability and performance under new conditions; these are company-asserted and not independently validated in the available data. No patents, regulatory certifications, or peer-reviewed publications are disclosed, and the operating footprint consists solely of the Edinburgh headquarters despite globally scoped distribution channels.

Name

Pharmatics

Legal name

Pharmatics Limited

Website

https://pharmaticsltd.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Pharmatics builds MedAI, a proprietary LLM- and NLP-driven pipeline that converts biomedical literature into evidence-based predictive models delivered via API, serving digital health solution providers, healthcare providers, and research organizations in precision medicine.

Ownership category

akta.pro rank

Product category

Digital Health AI Platform

NAICS

Software Publishers (513210), Software Publishers (5132), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAGAJAO

AI/ML Platforms for Drug Discovery & Experiment Optimization

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAGAJAF

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

• Health AI platform
• Biomedical predictive analytics
• Precision medicine AI
• Evidence-based modeling
• Digital health AI

Headquarters

HQ city

Edinburgh

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. MedAI Services: The company provides AI development services combining learning from data with up-to-date medical evidence. Services include synthesis of predictive models from biomedical scientific articles and trials, clinical expertise, and explainable predictions. Revenue appears to be generated through project-based engagements and API access services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels2 records

Core offering

Pharmatics provides MedAI, an AI pipeline that uses Large Language Models, natural language processing, and information retrieval to automatically transform biomedical scientific articles, clinical trials, and systematic reviews into evidence-based predictive models accessible via API. The company offers three complementary services: Evidence (synthesis of predictive models from biomedical literature), Data (AI/ML development using real-world health data, biomarkers, sensors, images, and PROMs), and Integration (API access and deployment of predictive models into client software products and apps).

Product overview

Pharmatics offers MedAI as its core AI technology platform, combined with three complementary services (Evidence, Data, and Integration). MedAI uses Large Language Models and natural language processing to transform biomedical publications into predictive tools accessible via API. The Evidence service synthesizes predictive models from scientific articles and clinical trials; the Data service provides AI/ML development using real-world health data; and the Integration service enables API access and deployment of predictive models within mobile or web apps and software services. Together, these offerings aim to reduce development time by 12-24 months and improve predictive performance by 10-30%.

Differentiator

Problem solved

Functional benefit

Brands

• MedAI: AI technology service that automatically transforms biomedical publications into predictive tools for science and medicine, enabling rapid deployment via an API. MedAI improves prediction quality and reduces bias in digital and precision health with knowledge-based transfer learning.

Products and services

• MedAI

Quantifiable outcome

• 18-month reduction in development time for digital health solutions
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Scale indicators5 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• Owkin: AI-for-healthcare company building ML models on multimodal clinical and biomedical data for pharma R&D and digital health partners. Comparable to Pharmatics because both serve as ML/AI platforms that augment clinical research and drug-development pipelines with AI-driven predictive modeling.
• BenevolentAI: U.K.-based AI platform applying knowledge graphs and ML to biomedical literature and clinical data to accelerate drug discovery. Comparable to Pharmatics' MedAI because both combine NLP/AI over scientific publications with predictive modelling for biomedical R&D.
• Insitro: ML-driven drug discovery and development company combining high-throughput biology with predictive models for pharma partners. Comparable to Pharmatics because both deliver ML-based predictive capabilities intended to accelerate and de-risk biomedical R&D for enterprise customers.
• PathAI: AI platform for pathology and biomarker quantification, providing ML-based predictive models to pharma and diagnostic partners. Comparable to Pharmatics because both offer ML-driven predictive tools on biomedical data, accessed by enterprise partners via integration/APIs.
• Exscientia: AI-native pharma company using ML to design and prioritize drug candidates, with published evidence-based predictive modelling capability. Comparable to Pharmatics because both target AI-driven drug discovery and clinical-trial acceleration through model-based inference over scientific evidence.
• Recursion Pharmaceuticals: AI-driven drug discovery platform generating proprietary biological datasets and ML models for therapeutics R&D. Comparable to Pharmatics because both apply ML to biomedical evidence to improve the speed and quality of preclinical and clinical R&D predictions.

Emerging players

• Deep 6 AI: AI platform for clinical trial feasibility and patient recruitment that mines EHR and clinical data using NLP/ML. Comparable to Pharmatics because both use NLP-driven extraction over biomedical/clinical text to support clinical-trial and R&D workflows.

Broad incumbents

• Health Catalyst: Enterprise analytics and AI platform for healthcare systems, with predictive models and data integration products sold to providers. Comparable to Pharmatics because both build predictive analytics offerings atop clinical and operational data for healthcare-enterprise buyers.
• Tempus Labs: Large precision-medicine platform combining multi-omic data with AI/ML to support clinical decisions and drug discovery. Comparable to Pharmatics because both provide AI-driven predictive tools in precision health, although Tempus operates at much larger scale across a broader portfolio.

Others

• Flatiron Health: Oncology-focused health-tech and real-world data platform with ML models for clinical research and care delivery. Comparable to Pharmatics because both convert clinical/real-world evidence into AI-ready assets and predictive models for research-oriented customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmatics